Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JonB
    Member
    • Jan 2010
    • 85

    #1

    Low mapping rate of TSS-data (5'-seq)

    Hi,

    We have performed transcription start site sequencing (TSS, 5'-sequencing) using TAP treatment (tap+ and tap- of totalRNA) and Illumina 100bp SE sequencing. I have quality trimmed the reads with Trimmomatic and mapped to the genome using TopHat2. For the tap+ reads, about 50% of the trimmed reads map to the genome, and for tap- only about 20% map.

    Have anyone experienced similar results? What could be the reasons for the low overall mapping rate, and why is the tap- data lower than tap+? I don't fully understand what is the effects of the tap-treatments, and what should be the expected differences between the two libraries. We are working on a non-model organism with a quite poorly assembled genome, but with regular mRNA-seq we usually have 80% mapping rate.
  • Michael.Ante
    Senior Member
    • Oct 2011
    • 127

    #2
    Hi JonB,
    are you using any other treatments to the total RNA? If not, maybe the rRNA is messing up your samples. Try to map the trimmed reads first to the rRNA sequences and continue with the unmapped reads with your TopHat2 alignment.
    Additionally, check if the tap+ and tap- mappings have major differences in junction detection. TopHat2 can be picky if it doesn't find any junctions.
    Cheers,
    Michael

    Comment

    • JonB
      Member
      • Jan 2010
      • 85

      #3
      Thanks!
      No we didn't deplete rRNAs, so definitely rRNAs represent a major fraction of the reads. But do you think this can explain the differences in mapping rate between tap+ and tap-? And should one expect differences between the two samples?

      Thanks for the advice about the junctions, I will look into that.

      Comment

      • Michael.Ante
        Senior Member
        • Oct 2011
        • 127

        #4
        AFAIK, tap treatment removes the cap from the RNA. Thus, all mRNA molecules in your tap+ sample are equally available to 5' ligation and other methods.
        Therefore, it should make a difference using tap in 5'-Seq assays.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          Yesterday, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 02:55 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...